Institutional investors purchased a net $160.8 thousand shares of RGEN during the quarter ended September 2014, and now own 88.12% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
OPPENHEIMERFUNDS, INC. Bought 564.5 Thousand shares of Repligen Corp
INVESCO POWERSHARES CAPITAL MANA... Bought 400.3 Thousand shares of Repligen Corp
FIDELITY MANAGEMENT & RESEARCH C... Bought 372.7 Thousand shares of Repligen Corp